Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 31-40 of 48 for Clinical Genomics

Edit search filters
  1. A Study of Genetic Testing in the Care of Glioma Patients

    Rochester, MN

  2. Testing of Real-Time Diagnostic Platform (HPView) for the Detection of High-risk HPV Strains in Urine

    Rochester, MN

  3. Testing the Biochemical Behavior of the Fecal Microbiome

    Rochester, MN

  4. A Study of Vaginal Microbial Signatures for Women with Refractory Symptoms of Bacterial Vaginosis or Vaginitis

    Rochester, MN

  5. A Study on Mayo Clinic Patients with Friedreich Ataxia

    Rochester, MN

  6. A study to create and analyze a comprehensive longitudinal resource using testing results from those with genetic risk of Alzheimer's disease

    Scottsdale/Phoenix, AZ

  7. A Study to Analyze the Microbiome and Immunology of the Lower and Upper Female Reproductive Tract in Women with Endometriosis

    Rochester, MN

  8. A Study to Evaluate Return of Pharmacogenomic Results Through Direct-to-Consumer Online Portal: Consumer Experiences

    Rochester, MN

  9. Inherited Muscle Diseases Repository

    Rochester, MN

  10. A Study to Explore Clinicians’ Point-Of-Care Decision-Making Process and Behavior following a Pharmacogenomics Alert

    Rochester, MN

.

Mayo Clinic Footer